INTRODUCTION
Oral cancer is the fifth most common type of cancer worldwide and second in the developing world. 1, 2 In the Indian subcontinent head and neck cancer (HNC) is the frequent malignancy, accounting up to 40-50% of all malignant cancers. 3 The incidence of HNC has significantly increased in the past 20 years and has become the fourth most common cause of cancer among men and third most common cancer among women in India. Among the major documented risk factors associated with HNC are tobacco smoking's, alcohol consumption followed by diet, oral health or exposure to environmental carcinogens. 2, [4] [5] [6] Carcinogenic molecules from these carcinogens are known to cause oxidative DNA damage to epithelial cells, but such damage is known to be corrected by some DNA repair mechanisms. 7, 8 It is also believed that along with the environmental factors, the host factors including individual's genetic susceptibility related to genetic polymorphisms of various genes including those involved in DNA repair pathway is also likely to play a role in the development of oral cancer. 9 Though the genetic factors are considered of great importance to cancer risk through the modulation of DNA repair but the genomic etiology of HNC is largely unknown.
There are three major pathways involved in DNA damage and repair which play a pivotal role in maintenance of genomic integrity such as base excision repair (BER), nucleotide excision repair (NER) and double strand break repair (DSBR). 10 But it is not yet clear which DNA repair pathways or enzymes are most important for protection against HNC. The NER pathway is an important mechanism that repairs DNA damage which involved in the removal of variety of bulky DNA lesions such as ultra violet light induced pyrimidine dimmer, other photoproducts, larger chemical adducts and crosslinks.
Human xenoderma pigmentosum complementation group D (XPD) is one of the major gene involved in NER pathway through recognition and repair of thymidine dimers. XPD have DNA helicase activity which participates in NER pathway and basal transcription through stabilizing the transcription factor complex TFIIH 11 . Hundreds of polymorphisms in DNA repair genes associated with cancer risk have been identified [12] [13] but their effects on repair function have not been well characterized.
Some of them are X-ray crosscomplementing group (XRCC), Xenoderma pigmentosun complementation group D (XPD), xenoderma pigmentosum complementation group C (XPC) and xenoderma pigmentosum complementation group G (XPG) which have been frequently studied and there is a growing body of evidence that polymorphisms of these genes may have some phenotypic significance. Previous studies on XPD suggested that XPD polymorphisms were associated with risk of skin cancer, breast cancer, gliomas, and bladder cancer in Caucasian, Americans, British and Chinese populations. [14] [15] [16] [17] [18] [19] Few molecular epidemiologic studies have evaluated the association of HNC with functional genetic variants in the XPD genes, but in some of the studies the results are contradictory rather than convincing. [20] [21] [22] [23] [24] [25] Also, the earlier observations were not consistent in terms of their roles in oral cancer susceptibility and therefore the influence of the polymorphisms of XPD genes on DNA repair capacity is still unclear. It is also uncertain which DNA repair pathway genes may be more important for protection against head and neck cancer. In earlier studies we have shown that polymorphisms in BER pathway genes especially XRCC1, XRCC4, XRCC5 and XRCC7 plays an important role in susceptibility of head and neck cancer in rural population of south-western Maharashtra, India. 26 In continuation with this, we also hypothesized that the inherited polymorphisms of NER pathway genes may contribute to genetic susceptibility to head and neck cancer. To test this hypothesis we also focused on different genetic polymorphisms of NER pathway genes especially XPD to evaluate their role in head and neck cancer if any.
We performed a hospital based case-control study using a polymerase chain reaction based restriction fragment length polymorphism (PCR-RFLP) assay to genotype the polymorphisms of selected DNA repair genes in relation to head and neck cancer susceptibility in a rural population of south-western Maharashtra from India. We determined the genotypic frequency of polymorphisms of the (A) XPD C22541A at codon 156 of the exon 6 (B) XPD C23047G at codon199 of the exon 8 (C) XPD G23592A at codon 312 in the exon 10 and (D) XPD A35931C at codon 751 in the exon 23 using the restriction enzymes TfiI, DpnII, StyI and PstI respectively. Multivariate logistic regression analysis was performed to calculate adjusted odds ratio (OR) and 95% confidence intervals (CIs).
METHODS
This study was a hospital based, case-control study conducted in rural areas of south-western Maharashtra from India. Study participants included 320 patients, newly diagnosed with head and neck cancer and 400 healthy, cancer free, age and sex matched individuals were selected as controls living in the same residential areas as the cases. All cases ranged in age from 30 -80 years (Mean±SD) 54.42±12.95 were recruited immediately after being diagnosed. Trained interviewers used a structured questionnaire to collect personal interview data from the participants regarding demographic factors and known risk factors including occupational history, dietary habits, smoking and drinking status and individual family history of diseases, including cancer.
Genomic DNA isolation from whole blood
Five milliliter (mL) of whole blood from patients and normal age matched controls was collected in sterile purple top vacutainer after receiving informed consent. Genomic DNA extraction was carried out from the peripheral blood sample using Purelink genomic DNA extraction and purification Kit (Invitrogen, Life technologies) following the manufacturer's instructions.
Genotyping assays
Genotyping of XPD gene were performed by PCR-RFLP methods with appropriate primer sets ( Table 1) . The primers were designed to amplify the regions of DNA that contain polymorphic sites of interest: (A) XPD C22541A codon 156 in the exon 6 (B) XPD C23047G at codon 199 of the exon 8 (C) XPD G23592A at codon 312 in the exon 10 and (D) XPD A35931C at codon 751 in the exon 23. The PCR amplification were carried out separately under different conditions in 20 micro liter (µL) reaction mixtures containing 1X PCR buffer (10 mili molar (mM) Tris-HCl (pH 9.0), 50 mM KCl 1.5 mM MgCl2, 0.01% gelatin), 0.2 mM each dNTP, 10 picomole (pmol) of each primer listed in Table- 1, 1U Taq DNA polymerase (GeNei, Merck Bioscience) and 100 nanogram (ng) of purified genomic DNA template. The reaction mixtures were subjected to PCR amplification with a Master Cycler Gradient PCR (Eppendorf). After performing PCR programme for each of the reactions, the PCR products were analyzed by agarose gel electrophoresis in TrisAcetate-EDTA (TAE) buffer.
The agarose gels were stained with ethidium bromide (10 mg/mL) and visualized under UV Transilluminator and photographed in gel documentation system (BioRad Laboratories). After confirmation of DNA amplification, each PCR product was digested with an appropriate restriction enzyme as shown in Table-1 for genotyping. Ten µL of the PCR products were digested at 37°C overnight with specific restriction enzymes in 20 µL reaction mixtures containing buffer supplied with each restriction enzyme. After the overnight incubation, digestion products were then separated on a 2-3% low EEO agarose (GeNei) gel at 100Volts for 30 min stained with ethidium bromide and photographed with gel documentation system.
Statistical analysis
All statistical analyses were performed using SPSS 11.5 for windows software. The associations between the XPD genotypes and risk of HNC with or without smoking and drinking history were studied using odds ratio (OR). Both the univariate and multivariate logistic regression analyses were employed to calculate the adjusted odds ratios (ORs) and 95% confidence intervals (CIs) to determine the cancer risk associated with genotypes.
RESULTS
During the study period, 320 patients with oral cancer met the eligibility criteria for this study and 400 controls were selected to match these cases. The characteristics of age and sex matched cases and controls are presented in The amplification of XPD codon 156 resulted in the product of 644 bp. The TfiI enzyme was used to detect the XPDC22541A at codon 156 of exon 6. The PCR amplified products upon treatment with TfiI yielded wildtype (22541C) alleles of 587, 57bp fragments, and the polymorphic (A) allele produces 3 fragments of 474, 113 and 57 bp ( Figure 1A ). The frequency of XPD 22541CC homozygotes was 53.75% in cases and 59.50 % in controls whereas the frequency of 22541A allele was lower but not significantly in the cases (13.75 %) than in the controls (10.0 %). The frequency of XPD22541 CA heterozygotes was 32.50 % in cases and 30.50 % in controls (Table 3) . Thus, the C→A polymorphism in 
(B) XPD C23047G codon199 exon 8
The C→G distribution in codon 199 of the exon 8 results in Ile →Met substitution. The frequency of XPD 23047 CC wild type homozygotes was 12.50 % in cases and 63.50 % in controls whereas XPD23047GG variant homozygotes were 63.75 % in cases and 11.0 % in controls.
The frequency of XPD23047CG heterozygotes was 23.75% in cases and 25.50% in controls (Table 3 ). The frequency of the XPD 23047G allele was significantly higher in cases (0.63) than in controls (0.11). (Table-3 ). This allele frequency in the controls was similar to previously reported studies. Table 4 : Stratification analysis of the demographic factors including age, tobacco smoking and alcohol drinking and distribution of genotypes with odds ratio of the XPD genes in the patients with head and neck cancer and the control group from rural population of south-western Maharashtra, India.
(D) XPD A35931C codon 751 exon23
The amplification of XPD codon 751 resulted in the product of 436 bp. The PstI enzyme was used to detect the XPDA35931C at codon 751 of exon 23. The PCR amplified products upon treatment with PstI yielded wildtype (35931A) alleles of 290, 146bp fragments, and the polymorphic (C) allele produces 3 fragments of 227, 146 and 63 bp ( Figure 1D ). The A→C polymorphism in exon 23 at nucleotide position 35931 gives rise to the amino acid substitution Lys→Gln in the codon 751. 27, 28 In our study the frequency of Met allele XPD 199 was 0.64 that of XPD 156 allele Arg was 0.13 and that of XPD 312 Asn allele was 0.21 and frequency of XPD 751 allele Gln was 0.16 which were to some extent different from other reports.
The polymorphism in DNA repair genes has been extensively investigated for its associations with cancer risk and the results were conflicting in different types of cancer or different populations. The investigations into the relationship between polymorphisms in DNA repair genes and susceptibility to environmental cancer have not yet produced consistent results. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] However, there is an inconsistency most likely due to the complexity of the biological process and of molecular epidemiological investigations.
Several molecular epidemiological studies have investigated the association between genetic polymorphisms in XPD and susceptibility to several kinds of cancers including skin cancer, breast cancer, gliomas and bladder cancer among different ethnic including Caucasian, Americans, British and Chinese populations. 14, [16] [17] [18] [19] 21 Whereas few other studies failed to find positive evidence for XPD polymorphisms in squamous cell carcinoma of the head and neck (SCCHN) or melanoma. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Very few studies from Northern and Southern India have reported the genetic polymorphisms in the DNA repair genes with respect to a variety of cancer risks including prostate, breast, oral and esophageal cancers. [33] [34] [35] However, very limited information is available on the association of genetic polymorphisms of DNA repair genes including NER pathway genes and their susceptibility to oral cancer from rural population of Maharashtra where the rate of tobacco and alcohol consumption is very high. Therefore in this study, we aimed to investigate the relationship between the development of oral cancer and genetic polymorphisms in XPD genes with respect to tobacco and alcohol exposure from a pool of unexplored rural Maharashtrian population. Such genotyping analysis of DNA repair genes will enhance our ability to identify those individuals most susceptible to tobacco and alcohol induced carcinogenesis in the rural population of southwestern Maharashtra.
CONCLUSION
This study is the first time to report the combined effects of XPD gene polymorphisms on the risk of head and neck cancer in Maharashtrian population. Our results showed that the XPD gene at position 23047 of codon 199 of exon 8 polymorphism which could be associated with the risk of oral cancer. This analysis of correlation of DNA repair genes and HNC may provide a deeper insight into the genetic and environment factors to cancer risk in the rural unexplored population.
